Eric Vessels, MD
Pain Medicine · Glasgow, KYNPI 1033351820
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,256 of the $2,661 with a category attached, or 84.8%. 20 manufacturers reported payments, led by Si-bone, Inc. at 39.8% of the total. Reporting peaked in 2024 at $1,101 and has fallen 55.0% since, to $495 in 2025. That places this record below the midpoint for pain medicine clinicians in KY, where the typical reported total is $3,535.
Across 80 payments — averaging $33.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$1K
- AbbVie$436
- Abbott$375
- Lundbeck LLC$238
- Revance Therapeutics, Inc.$91
- Lilly USA, LLC$50
- plus $411 from 14 others
What the payments were for
- Travel & lodging$40515%
- Food & beverage$2,25685%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 12 | $1,060 |
| AbbVie(2 entities) | 20 | $436 |
| Abbott | 10 | $375 |
| Lundbeck LLC | 10 | $238 |
| Revance Therapeutics, Inc. | 3 | $91 |
| Lilly USA, LLC | 3 | $50 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $47 |
| Stryker | 1 | $43 |
| Biohaven Pharmaceuticals, Inc. | 2 | $42 |
| Novartis | 2 | $35 |
| Pacira Pharmaceuticals Incorporated | 1 | $35 |
| Amgen | 2 | $34 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Collegium Pharmaceutical, Inc. | 2 | $26 |
| Averitas Pharma Inc. | 1 | $24 |
| Relievant Medsystems, Inc. | 2 | $24 |
| Valinor Pharma, LLC | 1 | $22 |
| Globus Medical | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Nevro Corp. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IFUSE IMPLANT SYSTEM$362
- PENTA$126
- PROCLAIM$120
- UBRELVY$112
How this compares
$2,661 in reported general payments places this provider in the 40th percentile of 90 pain medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 115 | $77,824 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,843 | $52,147 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,907 | $43,733 |
| Xtampza ErOxycodone Myristate | 38 | $28,719 |
| BotoxOnabotulinumtoxina | 18 | $23,628 |
| Fentanyl | 155 | $17,259 |
| Oxycodone Hcl | 635 | $15,421 |
| Morphine Sulfate ErMorphine Sulfate | 333 | $15,286 |
| Gabapentin | 794 | $6,756 |
| Nucynta ErTapentadol Hcl | 12 | $3,864 |
| Pregabalin | 177 | $2,590 |
| Lidocaine | 20 | $1,260 |
| Morphine Sulfate | 68 | $1,214 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 20 | $704 |
| Methadone Hcl | 45 | $703 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er | $26 | $32,58350 claims |
| AbbVieBotox | $436 | $23,62818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 90 pain medicine providers in Kentucky.
Other pain medicine in Glasgow
- Shammi PatelGlasgow$13K
- Anjum BuxDanville$595K
- Christopher MallardLexington$47K
- Vinod MuniswamyGeorgetown$39K
- John RuxerPaducah$33K
- Timothy BeachamLouisville$31K
- Mazhar RasulLexington$30K
- Tejas ShahAshland$23K
- Lance HoffmanFlorence$22K
- Jonathan GraingerFlorence$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.